EDGAR Filing Documents for 0001367920-15-000005

Form 8-K - Current report:

SEC Accession No. 0001367920-15-000005

Filing Date

2015-11-05

Accepted

2015-11-05 07:49:10

Documents

Period of Report

2015-11-05

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	q3earningsrelease-8xk.htm	8-K	30448
2	EXHIBIT 99.1	q315earningsrelease.htm	EX-99.1	103038
3		concertimage8k.jpg	GRAPHIC	15744
	Complete submission text file	0001367920-15-000005.txt		156510

Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421

Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045

CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 151198847
SIC: 2834 Pharmaceutical Preparations